Please login to the form below
priority access
This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.
WHO says 172 countries are poised to participate in COVID-19 vaccine initiative
It is the only global initiative working with governments and manufacturers to ensure equitable access to COVID-19 vaccines. ... vulnerability, with front-line health and social care workers to be given priority.
Latest news
-
The NHS is facing shortages of lifesaving treatments, says internal document
The document also apparently told doctors that certain patients would need to have priority over others for access to lifesaving drugs. Recommendations for rationing in the document included breaking tablets in ... You may wish to consider the following
-
NHS England says yes to Roche's Hemlibra
which has ensured access to emicizumab for patients with inhibitors with limited treatment options.”. ... Hemlibra's market access was agreed outside the normal framework of NHS England's specialised commissioning, which ranks treatments and procedures
-
Amgen gets prevention claim for cholesterol drug Repatha
Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that
-
GSK tops Access to Medicines Index for fifth time running
Only 5% of products covered by pricing strategies currently meet affordability criteria in priority access countries, according to the 2016 Index, despite companies increasingly waiving patent rights in priority regions. ... The Access to Medicines Index
-
Ready for takeoff?
The most popular of the early access options is the Adaptive Pathway Pilot Programme, a precursor to PRIME. ... All sectors within the pharmaceutical industry will benefit from greater access to innovative new medicines across the EU.
More from news
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Building BRICs: pharma's key emerging markets are becoming giants
Further, the inference that locally-produced drugs may gain preferential access to state reimbursement lists has provided an added incentive for international manufacturers to invest in Russian infrastructure. ... Improving access to healthcare remains a
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
